Submitting OIG:
Report Description:
Medicare Part B paid for some immunosuppressive drugs billed with the KX modifier that were not eligible for Part B payment. Of the 75 claims in our random sample, pharmacies had documentation to support the KX modifier for 65 claims but did not have support for the remaining 10.
Date Issued:
Friday, August 25, 2017
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
A-06-15-00018
Component, if applicable:
Centers for Medicare & Medicaid Services
Location(s):
Agency-Wide
Type of Report:
Audit
Questioned Costs:
$0
Funds for Better Use:
$0
Number of Recommendations:
2
View Document:
Attachment | Size |
---|---|
61500018.pdf | 1.12 MB |
Additional Details Link: